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What Can Microdialysis Tell Us About the Temporal
and Spatial Generation of Cytokines in Allergen-
Induced Responses in Human Skin In Vivo?
Geraldine F. Clough1, Claire L. Jackson1, Jacob J.P. Lee1, Sarah C. Jamal1 and Martin K. Church1
This study examined the suitability of microdialysis to assess the time course of cytokine generation from
discrete sites within the skin following intradermal injection of allergen. Cytokines were recovered using two
microdialysis probes, one close to the point of allergen injection and the other 1 cm away but within the area of
the late-phase induration. Skin biopsies taken at both sites were stained immunocytochemically to investigate
possible relationships between cytokine generation, expression of adhesion molecules, and recruitment of
neutrophils and eosinophils during the late-phase allergic response. The cytokine response to probe insertion
was assessed using a single probe in the opposite arm (control). At baseline, microdialysate contained low
levels of IL-1a, IL-5, IL-8, IL-12, GM-CSF, and TNFa (n¼ 27–33). At control sites, this was followed by increases in IL-
6 and IL-8 at 3 and 6 hours. Allergen increased TNFa levels in 3/11 individuals within 30 minutes at the injection
site. Levels of IL-6 and IL-8 rose rapidly and were significantly greater (Po0.05) than that of controls at 3 and
6 hours at both injection and distant sites. Adhesion molecule expression and leukocyte infiltration were
elevated only at the allergen injection site, suggesting a complex relationship between cytokine generation and
cellular events in allergic inflammation. In conclusion, microdialysis can be used to distinguish temporal and
spatial changes in protein profiles in the skin. Furthermore, when used in conjunction with skin biopsies, it
provides novel information about the mechanisms of dermal inflammation.
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INTRODUCTION
The ability to control inflammation, modulate immunological
diseases, or accelerate tissue repair remains elusive largely
because of the complexity of cytokine networks involved in
their etiology. Great advances in understanding cytokine
networks in disease have been made by studying biopsies,
using isolated cells in vitro, and developing murine models of
human disease (Izuhara, 2003; Gutermuth et al., 2004;
Pivarcsi and Homey, 2005; Hennino et al., 2006). However,
in order to understand more clearly the mechanisms under-
lying the initiation and development of human diseases at a
local level, it is necessary to be able to gain an insight into
both the temporal and the spatial generation of cytokines.
Many methods have been used to sample body fluids in
order to measure the mediators generated from local
inflammatory responses in the skin. Perhaps the easiest
method is to take a blood sample. While this may be useful to
measure the time course of the release of mediators, it gives
little information about their source. Also, it may grossly
underestimate mediator levels coming from a local inflam-
matory reaction (Heavey et al., 1984; Petersen et al., 1997a),
while overestimating skin levels of mediators generated
during a systemic response (Nedrebo et al., 2004). At the
opposite end of the scale, cytokines have been successfully
measured in the extracellular fluid extracted from biopsies of
rat skin by centrifugation (Nedrebo et al., 2004). While this
technique allows the measurement of cytokines at discrete
sites, it may not be ethically acceptable in human volunteers
because, to establish a time course of cytokine generation,
multiple biopsies are necessary, each one of which leaves a
permanent scar.
The method most often used to measure the local
generation of cytokines in humans is the raising of skin blisters
(Zweiman et al., 1997; Teunissen et al., 2002). However,
Zweiman et al. (1997) reported that the trauma of raising the
blister and the fitting of a skin chamber stimulated the
generation of high levels of IL-6 and IL-8 with lower levels
of RANTES and IL-1b in fluid sampled at 5 hours. Furthermore,
this technique cannot be used in damaged or abraded skin.
Microdialysis is a well-established technique for the
continuous sampling of small, water-soluble molecules
within the extracellular fluid space in vivo. It has the
advantage over other sampling techniques in that it can be
used in intact tissues to follow temporal variations in the
generation and the release of substances at discreet locations
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within the tissue space. Since its initial use in the brain of
experimental animals for the recovery of neurotransmitters
and other small hydrophilic solutes, microdialysis has been
adapted for use in many other tissues including skin, adipose
tissue, muscle, and the gastrointestinal tract (Clough, 2005).
The recent development of large pore membranes (molecular
mass cutoff 4100,000 Da) has facilitated the use of micro-
dialysis in the recovery of larger proteins and macromole-
cules from the tissue space (Sjogren et al., 2002; Winter et al.,
2002, 2004; Averbeck et al., 2006).
In our study, we have used the allergen-induced wheal-
and-flare response as a model to explore the ability of
microdialysis to detect temporal and spatial changes in
cytokine generation and investigate possible relationships
between cytokine generation and the expression of adhesion
molecules and the recruitment of neutrophils and eosino-
phils. By inserting a separate probe into the opposite arm, the
generation of cytokines in response to dermal injury caused
by probe insertion was also investigated.
RESULTS
Macroscopical events in the skin
All participants developed a transient edema at the sites of
implantation of microdialysis probes, which regressed within
112 hours. The injection of saline produced a small wheal,
which resolved within 15 minutes.
Allergen injection stimulated the development of wheal-and-
flare responses, the mean areas of which were 1.4270.14
and 24.3372.86 cm2 (mean7SEM) respectively at 15 min-
utes after challenge. This was followed by a late-phase
response that became macroscopically obvious from around
3 hours and had a mean area of 40.475.2 cm2 at 6 hours after
allergen challenge (Figure 1).
Cytokines
The release of selected cytokines in individual subjects is
shown in Figure 2 and the mean levels7SEM in Table 1.
Cytokine response to dialysis probe insertion. Microdialysis
fluid was collected between 1 and 112 hours after probe insertion
for measurement of ‘‘baseline’’ cytokine levels. The mean
cytokine levels7SEM (pg/ml) recovered from all three probes in
all 11 volunteers were as follows: IL-1a 12.976.0; IL-8
5.071.4; IL-12 5.872.3; GM-CSF 5.672.2; and TNFa
7.473.1 (all n¼ 33). IL-5 at baseline was 10.372.4 pg/ml
(a total of 27 probes in 9 volunteers). IL-1b, IL-2, IL-4, IL-6, IL-7,
IL-10, and IFNg were all below the level of detection of the
assay.
Control site. The levels of all cytokines recovered during the
30-minute period after injection of saline were not signifi-
cantly different from baseline levels.
The levels of IL-1a recovered at both 3 and 6 hours were
almost 50 pg/ml, significantly (P¼0.02) higher than those
recovered at baseline (Table 1 and Figure 2). In contrast, the
concentration of IL-1b recovered at 3 hours was below the
level of detection, and only a small, but statistically
significant (Po0.02) increase was detected at 6 hours.
The largest cytokine increases seen at 3 and 6 hours after
probe insertion were in IL-6 and IL-8 (Table 1 and Figure 2).
IL-6 appeared to reach a maximum at 3 hours, with no
significant difference (P¼0.69) between the mean levels
detected at 3 and 6 hours. In contrast, the mean level of IL-8
recovered at 6 hours was significantly (P¼ 0.004) greater than
that recovered at 3 hours. There were statistically significant
correlations between IL-6 and IL-8 levels detected at both
3 hours (P¼ 0.008) and 6 hours (P¼0.006).
No significant increases in the levels of any other cytokine
were seen at any time.
Allergen challenge site. The levels of IL-1a recovered at both
3 and 6 hours, but not those recovered during the 30-minute
period after injection of allergen, were significantly higher than
those recovered at baseline (Table 1 and Figure 2). Although
the levels of IL-1a at 3 and 6 hours at the challenge site were
numerically higher than those at the control site at the same
times, the difference was not statistically significant as it was
mainly due to a large response in one individual (Figure 2).
With IL-1b, there were small but significant increases in
cytokine recovery at 3 and 6 hours. There were no significant
differences between levels of IL-1b recovered at the control
and allergen challenge sites.
There were significant increases above baseline in the levels
of IL-6 at 30 minutes, 3 hours, and 6 hours, and of IL-8 at 3 and
6 hours (Table 1 and Figure 2). These increases were
significantly greater (Po0.05 at all times) than those seen at
the control site. The level of IL-8, but not IL-6, was significantly
(P¼0.036) higher at 6 hours than 3 hours. There were
statistically significant correlations between IL-6 and IL-8 levels
detected at both 3 hours (P¼0.013) and 6 hours (Po0.001).
There was no significant correlation between the levels of
either cytokine and the area of the late-phase response.
The levels of TNFa recovered at the site of allergen
challenge deserve special mention. Three individuals had
significantly higher baseline levels of TNFa than the other
eight (19.672.1 vs 1.170.8 pg/ml, P¼0.015). In these three
individuals, the level of TNFa rose to 58.776.6 pg/ml
(P¼0.045 vs baseline) but had returned to baseline levels
2 cm
Figure 1. Photograph of a late-phase response at 6 hours after allergen
challenge. The arrow indicates the site of the allergen injection, close to and
halfway along the left-hand fiber, and the dotted line outlines the area of the
late-phase response.
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Figure 2. Graphs show cytokine recovery from individual volunteers. Data are from three sites: ‘‘Control’’, probe insertion site in the arm opposite to
that of allergen challenge; ‘‘Challenge site’’, the site of allergen challenge; and ‘‘1 cm from challenge’’, the site 1 cm away from the allergen injection. The
periods of dialysate collection were ‘‘Baseline’’, the 30 minutes period immediately before injection of allergen or saline (control); ‘‘30 minutes’’, the
30-minute period immediately following injection of allergen or saline; ‘‘3 hours’’, 3–312 hours after injection of allergen or saline; and ‘‘6 hours’’, 6–6
1
2 hours
after injection of allergen or saline.
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by 3 hours (Figure 2). No rise in TNFa was detected in the
other eight individuals.
There were no significant allergen-induced increases in
IL-2, IL-4, IL-7, IL-10, IL-12, IFNg, and GM-CSF up to 6 hours
after challenge. Of the Th2 cytokines, IL-4 remained below
the level of detection at all times, while IL-5, although
detectable at all times, did not rise. At the allergen injection
site, the mean level of IL-5 was 8.2574.57 pg/ml at baseline
and 6.8571.76 pg/ml at 6 hours.
Site 1 cm from the allergen challenge site. At the site
1 cm away from allergen challenge, there was a
variable elevation in IL-1a levels (Figure 2), the mean levels
not being statistically significantly different from baseline
at 30 minutes or 3 hours. At 6 hours, IL-1a levels were
statistically significantly (P¼ 0.004) higher than baseline
values but not statistically significantly different from
either the control or allergen challenge sites at the same
time.
Similar to the allergen challenge site, there were
significant increases of IL-6 above baseline at 30 minutes,
3 hours, and 6 hours, and of IL-8 at 3 and 6 hours at the site
1 cm away from the challenge site (Table 1 and Figure 2).
Again, the level of IL-8, but not IL-6, was significantly
(P¼0.016) higher at 6 hours than 3 hours. Unlike at the
challenge site, there were no statistically significant correla-
tions between IL-6 and IL-8 levels detected at either 3 hours
(P¼0.405) or 6 hours (P¼0.728).
Table 1. Mean (7SEM) cytokine levels recovered from the skin by microdialysis
Cytokine Baseline 30 minutes 3 hours 6 hours
IL-1a
Control 8.873.3 3.371.8 47.6717.0 47.6716.7
NS P=0.02 P=0.02
Challenge 6.072.1 4.972.9 86.3749.5 71.6735.2
NS P=0.004 P=0.02
1 cm away 7.671.8 8.774.3 51.9720.2 75.4719.3
NS NS P=0.004
IL-1b
Control 1.270.7 0.570.2 1.370.9 4.671.9
NS NS P=0.02
Challenge 1.270.6 2.071.1 4.171.6 9.874.7
NS. P=0.008 P=0.008
1 cm away 1.070.6 1.170.8 3.271.3 8.77 2.6
NS NS P=0.002
IL-6
Control 2.071.0 7.072.7 137.1727.1 174.2742.6
NS P=0.001 P=0.001
Challenge 3.771.6 37.2713.4 513.67124.1 381.6784.1
P=0.006 P=0.001 P=0.001
1 cm away 3.371.8 31.4711.5 354.9770.1 485.6795.4
P=0.006 P=0.001 P=0.001
IL-8
Control 5.472.8 7.672.7 116.9738.2 333.97112.9
NS P=0.002 P=0.001
Challenge 4.672.1 35.8724.7 408.4793.7 732.4793.6
NS P=0.001 P=0.001
1 cm away 4.972.3 7.572.7 227.5784.1 713.97147.4
NS P=0.001 P=0.001
NS, nonsignificant; SEM, standard error of the mean.
Data are from three sites: ‘‘Control’’’, probe insertion in the arm opposite to that of allergen challenge; ‘‘Challenge’’’, the site of allergen challenge;
and ‘‘1 cm away’’, the site 1 cm away from the allergen challenge site. The periods of dialysate collection were ‘‘Baseline’’, the 30-minute period
immediately before injection of allergen or saline (control); ‘‘30 minutes’’, the 30-minute period immediately following injection of allergen or
saline; ‘‘3 hours’’, 3–312 hours after injection of allergen or saline; and ‘‘6 hours’’, 6–6
1
2 hours after injection of allergen or saline. P-values indicate statistical
significance of differences from baseline measurements.
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TNFa levels remained close to baseline at all times as did
all the other cytokines assayed.
Adhesion molecules and cellular influx
The expression of adhesion molecules and cellular influx was
assessed 6 hours after allergen injection in biopsies from six
different volunteers. The expression of all adhesion proteins
(Figure 3) was significantly higher at the site of injection
compared with that 1 cm away, the respective numbers of
positive cells/mm2 being 14.273.3 and 2.471.7 (P¼0.02)
for E-selectin, 17.0273.3 and 3.471.4 (P¼0.025) for ICAM-
1, and 3.070.8 and 0.270.1 (P¼0.016) for VCAM-1.
The influx of neutrophils and eosinophils was assessed
6 hours after allergen injection in the same biopsies used for
the expression of adhesion proteins (Figure 4). The numbers
of both cells were significantly higher at the site of injection
compared with that 1 cm away, the respective numbers of
positive cells/mm2 being 495750 and 7.673.0 (Po0.0001)
for neutrophils and 42.9717.7 and 11.077.9 (P¼ 0.044) for
eosinophils.
DISCUSSION
In this study, we have used microdialysis and multiple
cytokine protein array analysis to assess cytokine generation
in human skin in vivo in real time. By using intradermal
allergen challenge as a model, we have shown that
microdialysis is able to detect temporal and spatial changes
in cytokine generation over and above those generated in
response to wounding caused by probe insertion. Also, by
comparing cytokine levels at 6 hours with microscopical
assessment of biopsies taken at the same time, we have
shown that it is possible to explore the relationships between
cytokine generation and the expression of adhesion
molecules and the recruitment of neutrophils and eosinophils.
While dermal microdialysis has been shown to recover
small hydrophilic molecules, such as histamine and nitric
oxide (Petersen et al., 1995; Clough et al., 2002), and
products of metabolism (Muller, 2002) with good efficiency,
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Figure 3. Expression of adhesion molecules. The number of nucleated blood vessel endothelial cells staining positive for E-selectin, ICAM-1,
and VCAM-1 6 hours after allergen challenge was assessed in biopsies from six volunteers. Biopsies were taken from the allergen challenge site (center) and
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Figure 4. Influx of neutrophils and eosinophils. The number of nucleated
cells staining positive for EG2 (eosinophils) or neutrophil elastase
(neutrophils) 6 hours after allergen challenge was assessed in biopsies from six
volunteers. Biopsies were taken from the allergen challenge site (center) and
1 cm away from the allergen challenge site.
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its ability to recover large relatively hydrophobic molecules,
such as cytokines which may adhere to tissue elements
surrounding the probe and/or to the probe membrane, is
much reduced (Ao et al., 2004). Using a commercial
membrane with a molecular cutoff of 100,000 Da, the
recovery of a number of cytokines, including IL-2, IL-4,
IL-5, IL-6, IFN-g, and TNFa, has been reported to be as low as
1% (Sjogren et al., 2002; Schutte et al., 2004; Waelgaard
et al., 2006). Recovery in vitro with dialysis probes having a
membrane with a molecular cutoff of 3,000,000 Da, as used
in our experiments, is higher, being 45% for IL-6, 28% for
IL-1a, 22% for nerve growth factor, and 18% for human
serum albumin (Winter et al., 2002).
A second factor that must be taken into consideration with
dermal microdialysis is the poor diffusibility of small
molecules such as histamine and sodium fluoride in the
skin, the maximum lateral diffusion of substances being
around 2 mm (Petersen et al., 1997b; Clough et al., 2002).
While this may be an advantage when investigating the
localization of released substances, it also means that
prolonged dialysis leads to a partial depletion of dialyzable
molecules in the immediate vicinity of the probes (Clough
et al., 2002). Thus, although it is scientifically legitimate for
us to cite only the cytokine levels present in the dialysate at
any time, local extracellular concentrations are likely to be
considerably greater.
Before discussing the effects of allergen challenge, it is
pertinent to discuss the stimulation of cytokine generation in
response to trauma caused by probe insertion. As would be
expected, levels of all cytokines were low or undetectable
1 hour after probe insertion. The observation that trauma
stimulated the generation of IL-6 and IL-8 extends previous
microdialysis and skin blister studies respectively (Sjogren
et al., 2002; Zweiman et al., 1997; Nocker et al., 1999;
Averbeck et al., 2006).
Following allergen injection, the levels of IL-6 and IL-8
recovered from the challenge site rose rapidly, reaching
levels significantly higher than those at the control site. These
data together with in vitro and in vivo studies in the airways
(Teran et al., 1996) confirm that IL-6 and IL-8 are generated
following allergen challenge. The observation that IL-6 levels
peaked by 3 hours agrees with the skin blister study of Lee
et al. (1992), who reported rapid generation of IL-6 with a
maximum at 312 hours after allergen challenge. As seen at the
control site, levels of IL-8 rose more slowly than those of IL-6,
not achieving statistical significance above baseline levels
until 3 hours and still rising at 6 hours. The observation that
the production of IL-8 was significantly increased by allergen
challenge agrees with the data of Zweiman et al. (1997) using
the skin window technique.
Increased levels of TNFa were found in the first 30-minute
collection period at the allergen challenge site only. The early
timing of the TNFa peak would support the suggestion of the
release of pre-formed TNFa from mast cells (Bradding et al.,
1995; Coward et al., 2002). Detectable increases of TNFa
were found in only 3/11 volunteers. Interestingly, in their skin
chamber study, Zweiman et al. (1997) found increased TNFa
in only 3/15 individuals following allergen challenge. This
suggests a great variation between individuals in the
generation of TNFa, which, in our study, did not correlate
with the production of other cytokines or the severity of other
features of the late-phase response.
Interestingly, levels of IL-6 and IL-8 were also increased
above control at the site 1 cm away from allergen challenge.
In contrast, no increased levels of TNFa were detectable at
this site. Thus, it is unlikely that increased levels of IL-6 and
IL-8 at the distant site were due to diffusion of the cytokines. It
is also unlikely to be a chemical signal diffusing through the
dermis or being carried by the blood or the lymphatics
because of their architectural arrangement. Therefore, it is
proposed that cytokines must be actively generated over a
wider area than the point of allergen injection. But how does
the message to generate cytokines get to the cells 1 cm away
from the site of challenge? There are two other more obvious
possibilities. The first is that cytokine secretion was stimu-
lated by the release of neuropeptides, particularly calcitonin
gene-related peptide (Schmelz et al., 1997). This is supported
by in vitro evidence that calcitonin gene-related peptide
stimulates the production of IL-6 in human fibroblasts (Sakuta
et al., 1995) and peripheral blood mononuclear cells (Cuesta
et al., 2002) and IL-8 in human synovial fibroblasts (Raap
et al., 2000) and monocytes (He et al., 2002). The second
possibility is that of conducted responses involving the
generation of electrical currents and Ca2þ signalling across
gap junctions of the arteriolar walls. Such mechanisms have
been previously shown in the regulation of vasomotor tone
(Dora et al., 2003).
In vitro studies have identified a wide spectrum of pro-
inflammatory cytokines to be released following allergen
challenge including a group of TH2-lymphocyte-associated
cytokines, IL-4, IL-5, and IL-13, which promote the develop-
ment of allergic response. Supporting evidence of their
involvement in allergy in vivo comes primarily from their
demonstration in bronchoalveolar lavage fluid (Broide and
Firestein, 1991; Virchow et al. 1995; Kroegel et al., 1996;
Teran et al., 1999; Batra et al., 2004; Julius et al., 2004). In
the skin, large numbers of cells both expressing IL-4 and IL-5
mRNA and staining for cytokine protein have been reported
to be present at the site of allergen-induced cutaneous late-
phase reactions in atopic subjects at 6 hours (Barata et al.,
1998). Consequently, we were a little surprised not to recover
increased amounts of either. There are several possible
explanations for this. First, IL-4 in particular is produced in
low levels and is not always detectable following allergen
challenge of the airways (Virchow et al. 1995). Second, the 6-
hour time point is too early for the generation of IL-4 and IL-5.
The majority of bronchial challenge studies have measured
cytokine generation 18 hours or later after allergen challenge
(Broide and Firestein, 1991; Virchow et al. 1995; Kroegel
et al., 1996; Teran et al., 1999; Batra et al., 2004; Julius et al.,
2004). However, in one study, a small increase in IL-5 levels
was detected in bronchoalveolar lavage at 4 hours (Teran
et al., 1999). Third, these cytokines remain cell associated so
that they cannot be recovered by dialysis in the skin.
At the site of allergen injection, biopsies taken at 6 hours
showed marked increases in the adhesion molecules
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E-selectin, ICAM-1, and VCAM-1. Also, there was a
65-fold increase in neutrophils and a 4-fold increase in
eosinophils, consistent with previous studies (Barata et al.,
1998; Litchfield et al., 1996). However, at the site 1 cm
away from allergen injection, there was little staining for
adhesion molecules and no inflammatory cell accumulation.
This was somewhat of a surprise considering that the levels of
IL-6 and IL-8, both of which have been reported to increase
adhesion molecule expression and inflammatory cell
accumulation (Borish et al., 1989; Douglass et al., 1996),
were similar to those recovered from the site of allergen
injection. Further, while endothelial cells are good producers
of the NF-kB-stimulated cytokines, IL-6 and IL-8, the genera-
tion of these cytokines is often accompanied by other NF-
kB-stimulated products, including the adhesion molecules
ICAM-1 and VCAM-1 (Lin et al., 2005). A possible suggestion
to explain this apparent anomaly is that IL-6 and IL-8 were
generated from non-vascular tissues such as fibroblasts (Kubo
and Kuroyanagi, 2005) rather than from endothelial cells.
In conclusion, we have shown that microdialysis in
combination with multiplex cytokine array assays can be
used to distinguish temporal and spatial changes in protein
profiles in the skin following both wounding and the
development of allergic inflammation. The observation that
adhesion molecule expression and leukocyte infiltration were
elevated at the site of allergen injection only suggests a
complex relationship between cytokine generation and the
cellular events occurring in allergic inflammation. Further-
more, when used in conjunction with other tissue-sampling
techniques, such as immunohistochemical analysis of skin
biopsies, microdialysis may be used to provide novel
information about disease mechanisms in the skin.
MATERIALS AND METHODS
Volunteers
Seventeen healthy, normotensive volunteers (15 male and 2 female;
age range 20–30 years) were recruited into the study. All gave a
positive skin prick test (weal of 5 mm in diameter at 10–15 minutes)
to either 6-grass mix or Dermatophagoides pteronyssinus (house dust
mite) (ALK, Horsholm, Denmark). The study was approved by the
Southampton & South West Hampshire Research Ethics Committee
(LREC 003/02) and conformed to the Declaration of Helsinki
Principles. All volunteers gave written informed consent. The study
was performed in the thermoneutral environment of the Wellcome
Trust Clinical Research Facility of Southampton General Hospital.
Microdialysis
Two linear cutaneous microdialysis membranes (3,000 kDa molecular
mass cutoff) were inserted 11 mm apart, into the volar surface of each
forearm of the volunteers, under topical local anesthesia (EMLA
cream, 2.5% prilocaine, 2.5% lidocaine, Astra Pharmaceuticals, Kings
Langley, UK). Each membrane ran for a length of 20 mm, at a depth of
approximately 0.7 mm. A 1-hour period was allowed for recovery
from local anesthesia and trauma before the start of perfusion with
Ringer’s solution at a rate of 5ml/min using a microinfusion pump.
Dialysate samples were collected in preweighed vials and stored at
–80oC before analysis. To assess baseline cytokine levels, dialysate
was collected from each probe for 30 minutes before the intradermal
injection in one arm of Timothy Grass or D. pteronyssinus extract (300
SQ units in 20ml Ringer’s solution). The injection was made 1 mm
from and parallel to the microdialysis fiber nearer to the wrist and
10 mm from the fiber further up the arm. An injection of the same
volume of Ringer’s solution (n¼ 8) or no injection (n ¼ 3) at the site
on the contralateral forearm served as a negative control site.
Dialysate was collected at timed intervals, 0–30 minutes (early),
3–312 hours (mid), and 6–6
1
2 hours (late) after intradermal injection.
Probe perfusion was stopped between collections.
Area of late-phase responses
The mean area of the late-phase response was measured by
planimetry 6 hours after allergen challenge.
Cytokine analysis
Dialysate cytokine content was assayed using a 16-well human
cytokine assay (Novagen Proteoplex) for IL-1a, 1b, 2, 4, 6, 7, 8, 10,
12, GM-CSF, IFNg, and TNFa. Dialysate samples were diluted 1 in 2
using the standard diluent provided. A four-point standard curve was
constructed at levels of 800, 400, 15, and 0 pg/ml. The detection
level was 5 pg/ml. IL-5 was assayed in undiluted dialysate samples
from nine volunteers using a separate enzyme immunometric assay
(TiterZyme) with a detection level of 3 pg/ml.
Determination of adhesion molecule expression and cellular
infiltration
Six hours after challenge, the area around the allergen injection and
an area 1 cm away but within the late-phase response induration
were infiltrated with 2% w/v lignocaine local anesthetic and then
3 mm punch biopsies were taken (Steifel Laboratories, Woburn
Green, UK). Each biopsy was divided into three, in order to obtain
pieces small enough for the satisfactory infiltration of fixative, and
fixed overnight in ice-cold acetone containing the enzyme inhibitors
iodoacetamide (20 mM) and phenyl methyl sulfonyl fluoride (PMSF,
2 mM). Specimens were then embedded in glycolmethacrylate (JB4
kit, Park Science Ltd, Northants, UK) as described previously
(Church et al., 2002). Sections of 2 mm thickness were cut and
stained immunocytochemically using biotinylated mouse anti-
mouse F(ab)2 (Dakopatts) as the secondary antibody (Church
et al., 2002). The following primary antibodies were used: E-selectin
(Chemicon, Temecula, CA); ICAM-1 (BioSource International,
Nivelles, Belgium); VCAM-1 (Serotec, Kidlington, UK); neutrophils
(anti-neutrophil elastase, DAKO Ltd, Cambridge, UK); and eosino-
phils, EG2 (Diagnostics Development, Uppsala, Sweden). Immuno-
cytochemically positive nucleated cells were counted in two high-
power fields and the average number was expressed as cells/mm2.
Statistical analyses
Results are expressed as mean7SEM. As it was not possible to
assume Gaussian distributions of the data, differences between
cytokine recoveries from the same dialysis probes at different times
were assessed by the Wilcoxon matched-pairs test and differences
between cytokine recoveries from dialysis probes at different sites by
the Mann–Whitney U-test.
CONFLICT OF INTEREST
The authors state no conflict of interest.
www.jidonline.org 2805
GF Clough et al.
Cytokine Microdialysis in Human Skin
REFERENCES
Ao X, Sellati TJ, Stenken JA (2004) Enhanced microdialysis relative recovery of
inflammatory cytokines using antibody-coated microspheres analyzed
by flow cytometry. Anal Chem 76:3777–84
Averbeck M, Beilharz S, Bauer M, Gebhardt C, Hartmann A, Hochleitner K
et al. (2006) In situ profiling and quantification of cytokines released
during ultraviolet B-induced inflammation by combining dermal
microdialysis and protein microarrays. Exp Dermatol 15:447–54
Barata LT, Ying S, Meng Q, Barkans J, Rajakulasingam K, Durham SR et al.
(1998) IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells
in allergen-induced late-phase cutaneous reactions in atopic subjects.
J Allergy Clin Immunol 101:222–30
Batra V, Musani AI, Hastie AT, Khurana S, Carpenter KA, Zangrilli JG et al.
(2004) Bronchoalveolar lavage fluid concentrations of transforming
growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after
segmental allergen challenge and their effects on alpha-smooth muscle
actin and collagen III synthesis by primary human lung fibroblasts. Clin
Exp Allergy 34:437–44
Borish L, Rosenbaum R, Albury L, Clark S (1989) Activation of neutrophils by
recombinant interleukin 6. Cell Immunol 121:280–9
Bradding P, Mediwake R, Feather IH, Madden J, Church MK, Holgate ST et al.
(1995) TNF-alpha is localized to nasal mucosal mast-cells and is released
in acute allergic rhinitis. Clin Exp Allergy 25:406–15
Broide DH, Firestein GS (1991) Endobronchial allergen challenge in asthma:
demonstration of cellular source of granulocyte macrophage colony-
stimulating factor by in situ hybridization. J Clin Invest 88:1048–53
Church MK, Griffiths TJ, Jeffery S, Ravell LC, Cowburn AS, Sampson AP et al.
(2002) Are cysteinyl leukotrienes involved in allergic responses in
human skin? Clin Exp Allergy 32:1013–9
Clough GF (2005) Microdialysis of large molecules. AAPS J 7:E686–92
Clough GF, Boutsiouki P, Church MK, Michel CC (2002) Effects of blood flow
on the in vivo recovery of a small diffusible molecule by microdialysis in
human skin. J Pharmacol Exp Ther 302:681–6
Coward WR, Okayama Y, Sagara H, Wilson SJ, Holgate ST, Church MK
(2002) NF-kappaB and TNF-alpha: a positive autocrine loop in human
lung mast cells? J Immunol 169:5287–93
Cuesta MC, Quintero L, Pons H, Suarez-Roca H (2002) Substance P and
calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha
secretion from human peripheral blood mononuclear cells. Neurochem
Int 40:301–6
Dora KA, Xia J, Duling BR (2003) Endothelial cell signaling during conducted
vasomotor responses. Am J Physiol Heart Circ Physiol 285:H119–26
Douglass J, Dhami D, Bulpitt M, Lindley IJ, Shute J, Church MK et al. (1996)
Intradermal challenge with interleukin-8 causes tissue oedema and
neutrophil accumulation in atopic and non-atopic human subjects. Clin
Exp Allergy 26:1371–9
Gutermuth J, Ollert M, Ring J, Behrendt H, Jakob T (2004) Mouse models of
atopic eczema critically evaluated. Int Arch Allergy Immunol 135:262–76
He Y, Ding G, Xia D, Zhu T, Fan S (2002) [Calcitonin gene-related peptide
induces chemokine interleukine-8 synthesis in human monocytes].
Zhonghua Yi Xue Za Zhi 82:131–4
Heavey DJ, Ind PW, Miyatake A, Brown MJ, MacDermot J, Dollery CT (1984)
Histamine released locally after intradermal antigen challenge in man.
Br J Clin Pharmacol 18:915–9
Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF (2006)
Pathophysiology of urticaria. Clin Rev Allergy Immunol 30:3–11
Izuhara K (2003) The role of interleukin-4 and interleukin-13 in the non-
immunologic aspects of asthma pathogenesis. Clin Chem Lab Med
41:860–4
Julius P, Hochheim D, Boser K, Schmidt S, Myrtek D, Bachert C et al. (2004)
Interleukin-5 receptors on human lung eosinophils after segmental
allergen challenge. Clin Exp Allergy 34:1064–70
Kroegel C, Julius P, Matthys H, Virchow JC Jr, Luttmann W (1996)
Endobronchial secretion of interleukin-13 following local allergen
challenge in atopic asthma: relationship to interleukin-4 and eosinophil
counts. Eur Respir J 9:899–904
Kubo K, Kuroyanagi Y (2005) A study of cytokines released from fibroblasts in
cultured dermal substitute. Artif Organs 29:845–9
Lee CE, Neuland ME, Teaford HG, Villacis BF, Dixon PS, Valtier S et al.
(1992) Interleukin-6 is released in the cutaneous response to allergen
challenge in atopic individuals. J Allergy Clin Immunol 89:1010–20
Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, Shiau AL et al. (2005) Expression
of cytokine, chemokine, and adhesion molecules during endothelial cell
activation induced by antibodies against dengue virus nonstructural
protein 1. J Immunol 174:395–403
Litchfield TM, Smith CH, Atkinson BA, Norris PG, Elliott P, Haskard DO et al.
(1996) Eosinophil infiltration into human skin is antigen-dependent in
the late-phase reaction. Br J Dermatol 134:997–1004
Muller M (2002) Science, medicine, and the future: microdialysis. BMJ
324:588–91
Nedrebo T, Reed RK, Jonsson R, Berg A, Wiig H (2004) Differential cytokine
response in interstitial fluid in skin and serum during experimental
inflammation in rats. J Physiol 556:193–202
Nocker RE, Out TA, Weller FR, Mul EP, Jansen HM, van der Zee JS (1999)
Influx of neutrophils into the airway lumen at 4 hours after segmental
allergen challenge in asthma. Int Arch Allergy Immunol 119:45–53
Petersen LJ, Church MK, Skov PS (1997b) Histamine is released in the wheal
but not the flare following challenge of human skin in vivo: a
microdialysis study. Clin Exp Allergy 27:284–95
Pivarcsi A, Homey B (2005) Chemokine networks in atopic dermatitis: traffic
signals of disease. Curr Allergy Asthma Rep 5:284–90
Raap T, Justen HP, Miller LE, Cutolo M, Scholmerich J, Straub RH (2000)
Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of
synovial fibroblasts in patients with rheumatoid arthritis compared to
osteoarthritis. J Rheumatol 27:2558–65
Sakuta H, Inaba K, Muramatsu S (1995) Calcitonin gene-related peptide enhances
cytokine-induced IL-6 production by fibroblasts. Cell Immunol 165:20–5
Schmelz M, Luz O, Averbeck B, Bickel A (1997) Plasma extravasation and
neuropeptide release in human skin as measured by intradermal
microdialysis. Neurosci Lett 230:117–20
Schutte RJ, Oshodi SA, Reichert WM (2004) In vitro characterization of
microdialysis sampling of macromolecules. Anal Chem 76:6058–63
Sjogren F, Svensson C, Anderson C (2002) Technical prerequisites for in vivo
microdialysis determination of interleukin-6 in human dermis. Br J
Dermatol 146:375–82
Teran LM, Carroll MP, Frew AJ, Redington AE, Davies DE, Lindley I et al.
(1996) Leukocyte recruitment after local endobronchial allergen
challenge in asthma. Relationship to procedure and to airway
interleukin-8 release. Am J Respir Crit Care Med 154:469–76
Teran LM, Carroll MP, Shute JK, Holgate ST (1999) Interleukin 5 release into
asthmatic airways 4 and 24 hours after endobronchial allergen chal-
lenge: its relationship with eosinophil recruitment. Cytokine 11:518–22
Teunissen MB, Piskin G, Di Nuzzo S, Sylva-Steenland RM, de Rie MA, Bos JD
(2002) Ultraviolet B radiation induces a transient appearance of IL-4+
neutrophils, which support the development of Th2 responses.
J Immunol 168:3732–9
Virchow JC Jr, Walker C, Hafner D, Kortsik C, Werner P, Matthys H et al. (1995)
T cells and cytokines in bronchoalveolar lavage fluid after segmental
allergen provocation in atopic asthma. Am J Respir Crit Care Med 151:960–8
Waelgaard L, Pharo A, Tonnessen TI, Mollnes TE (2006) Microdialysis for
monitoring inflammation: efficient recovery of cytokines and anaphylo-
toxins provided optimal catheter pore size and fluid velocity conditions.
Scand J Immunol 64:345–52
Winter CD, Iannotti F, Pringle AK, Trikkas C, Clough GF, Church MK (2002)
A microdialysis method for the recovery of IL-1beta, IL-6 and nerve
growth factor from human brain in vivo. J Neurosci Methods 119:45–50
Winter CD, Pringle AK, Clough GF, Church MK (2004) Raised parenchymal
interleukin-6 levels correlate with improved outcome after traumatic
brain injury. Brain 127:315–20
Zweiman B, Kaplan AP, Tong L, Moskovitz AR (1997) Cytokine levels and
inflammatory responses in developing late-phase allergic reactions in the
skin. J Allergy Clin Immunol 100:104–9
2806 Journal of Investigative Dermatology (2007), Volume 127
GF Clough et al.
Cytokine Microdialysis in Human Skin
